Home » Clinical Trials »  Search Clinical Trials

Therapeutic Areas:  |  Dermatology  |  Family Medicine

Search Medical Condition
Please enter condition
Please choose location from dropdown

Acne Clinical Trials

A listing of Acne medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (102) clinical trials

Primary end point: To evaluate the safety and tolerability of INCB054707. Secondary end point: To evaluate the systemic exposure and evaluate the efficacy of INCB054707. Overall design: This is a Phase 2, multicenter, open-label, single-arm study to assess the safety of 15 mg QD INCB054707 over 8 weeks in men and women aged 18 ...

Phase

Bothered by Rosacea on Your Face? Join a clinical research study of the safety and effectiveness of an investigational spray for people with mild to moderate rosacea. Participants will use the product twice a day for eight weeks.

Phase N/A

Concerned about what Rosacea is doing to your skin? Wake Research Associates is enrolling volunteers with moderate to severe rosacea in a study testing an investigational medication.  

Phase N/A

Concerned about what Rosacea is doing to your skin? Medical Center for Clinical Research is enrolling volunteers with moderate to severe rosacea in a study testing an investigational medication.

Phase N/A

Primary end point: To determine the safety and tolerability of INCB054707. Key Secondary end point: To determine the systemic exposure to INCB054707 and to determine the efficacy of INCB054707. Overall design: Population: Men and women aged 18 to 75 years with moderate to severe HS for at least 6 months. ...

Phase

A National Registry For Patients With Hidradenitis Suppurativa

The goal of this study is to get a better understanding of the skin condition, Hidradenitis Suppurativa, and to find out how the disease affects quality of life. Through internet groups and the American Academy of Dermatology, we propose to enroll greater than 200 enrollees in the first two years ...

Phase N/A

Open Label Study to Assess the Effect of Secukinumab in Moderate to Severe Papulopustular Rosacea

Rosacea is a common inflammatory skin disease affecting up to 10% of adults. Despite this, the etiology of rosacea is unclear, although there may be a genetic predisposition (Chang et al., 2015). Currently, there is no cure. Rosacea can lead to scarring, itching, burning, and is associated with anxiety and ...

Phase

Effect of Sclerotherapy on Fistulas and Sinus Tracts in Hidradenitis Suppurativa

This study evaluates the effect of hypertonic saline 23.4% injection in fistulas or sinus tracts in adult patients with hidradenitis suppurativa.

Phase

The Use of Oracea and Epiduo Forte in Severe Acne Patients

This is a single-center, open label pilot study. The study is comprised of 5 study visits; Screening, Baseline, and weeks 4,8, and 12. All subjects will receive Oracea once daily (QD) and Epiduo Forte at Baseline. WE will evaluate Investigator Global Assessment (IGA), total lesion count, adverse events and concomitant ...

Phase

Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa

Secukinumab is an antibody that inhibits Interleukin-17A, and IL-17 promotes neutrophil activities. Neutrophils are found in large numbers in HS. The expression of the inflammatory cytokines IL-17, IL-1, and TNF- were enhanced in lesional skin of HS patients. Prior studies have demonstrated improvement in HS with biologic medications such as ...

Phase N/A